Sort
141,003 grants matching “cytokine”
B cell determinants of EBV latency
$864,001Ethel Cesarman · Weill Medical Coll Of Cornell Univ · U01 · FY2022 · CA
Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling
$863,906Jason S Debley · Seattle Children'S Hospital · R01 · FY2023 · AI
Integration of Genomics and the Environment
$863,752Andrew P Feinberg · Johns Hopkins University · RM1 · FY2017 · HG
Innate Immune Regulation of Zika Virus Infection
$863,742Michael J Gale · University Of Washington · R01 · FY2019 · AI
Clinical trials employing cancer vaccine combination therapies
$863,733James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
$863,694Thomas M Lietman · University Of California, San Francisco · UG1 · FY2021 · EY
NIH Chronic GVHD Study Group
$863,692Steven Pavletic · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Human Immunology Center at the University of Rochester
$863,413Tim Mosmann · University Of Rochester · R24 · FY2012 · AI
Imaging of Aortic Atherosclerosis and Inflammation in the Metabolic Syndrome
$863,379Warren J Manning · Beth Israel Deaconess Medical Center · R01 · FY2008 · HL
IMPACT OF FARMING ENVIRONMENT ON IMMUNE MATURATION AND RESPIRATORY HEALTH
$863,116James E. Gern · University Of Wisconsin-Madison · U19 · FY2015 · AI
Cadaveric Donor Lung and Bone Marrow Transplantation in Immunodeficiency Diseases
$863,011Paul Szabolcs · University Of Pittsburgh At Pittsburgh · U01 · FY2020 · AI
AIDS and Opiates: A Monkey Model
$862,932Emory University · R01 · FY2003 · DA
Cross talk between keratinocytes and skin-resident T-cells influences HSV recurrence
$862,878Jia Zhu · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
Angiogenesis and Tumor Growth
$862,835Giovanna Tosato · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
Approaches To Immunological Intervention In Schistosomiasis
$862,767Thomas Wynn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma
$862,729Damian J. Green · Fred Hutchinson Cancer Center · P01 · FY2022 · CA
Novel Adjuvant Discovery in Vaccine Therapy
$862,703Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2010 · AI
Systematic Investigation of Protein Ubiquitination in ARDS
$862,581Beibei Chen · University Of Pittsburgh At Pittsburgh · R35 · FY2019 · HL
Perinatal Programming of Infant Stress Reactivity and the Atopic Phenotype
$862,538Rosalind J Wright · Brigham And Women'S Hospital · R01 · FY2010 · HL
Human Immunology Center at the University of Rochester
$862,408Tim Mosmann · University Of Rochester · R24 · FY2011 · AI
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)
$862,255David W Crabb · Indiana University Indianapolis · U01 · FY2016 · AA
Clinical Research and Assay Support
$862,242Mary Walter · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2017 · DK
Impact of Infection and Inflammation on Primitive Hematopoiesis
$862,071Katherine Yudeh King · Baylor College Of Medicine · R35 · FY2022 · HL
Severe Malaria And Risk to The Brain (SMART Brain)
$862,047Chandy C. John · Indiana University Indianapolis · R01 · FY2025 · NS
BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma
$861,992Damian J. Green · Fred Hutchinson Cancer Research Center · P01 · FY2020 · CA